Literature DB >> 6061822

Potentiation of acetohexamide hypoglycemia by phenylbutazone.

J B Field, M Ohta, C Boyle, A Remer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6061822     DOI: 10.1056/NEJM196710262771701

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

Review 2.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

3.  Drug interactions in paediatrics.

Authors:  M L Magotra
Journal:  Indian J Pediatr       Date:  1974-06       Impact factor: 1.967

4.  [Influence of liver diseases and kidney function disorders and phenylbutazone, phenprocoumarol and doxycycline on the excretion of glycodiazine].

Authors:  H Held; B Kaminski; H F von Oldershausen
Journal:  Diabetologia       Date:  1970-08       Impact factor: 10.122

5.  Non-steroid anti-inflammatory agents.

Authors: 
Journal:  Br Med J       Date:  1970-08-22

6.  Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.

Authors:  R J Lewis; W F Trager; K K Chan; A Breckenridge; M Orme; M Roland; W Schary
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

7.  Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions.

Authors:  G B Bolli; E Tsalikian; M W Haymond; P E Cryer; J E Gerich
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

Review 8.  Clinical pharmacokinetics of phenylbutazone.

Authors:  J Aarbakke
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

Review 9.  Drug interactions and clinical pharmacokinetics.

Authors:  M B Kristensen
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 10.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.